CooperCompanies to Participate in Upcoming Investor Conferences

CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced its participation in the following upcoming investor conferences:

2024 Wells Fargo Healthcare ConferenceWednesday, September 4, 2024, at 3:45 pm ETAl White, President & Chief Executive Officer, will represent the Company in a fireside chat

Morgan Stanley Annual Global Healthcare Conference Thursday, September 5, 2024, at 1:50 pm ETAl White, President & Chief Executive Officer, will represent the Company in a fireside chat

A webcast of each session will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com.

About CooperCompanies

CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies (“Cooper”) has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com.

Contact:Kim DuncanVice President, Investor Relations and Risk [e-mail]